N/A N=22 Randomized Double-blind Treatment

Enhancing Emotion Regulation During Driving in OEF/OIF Veterans

Driving Distress Secondary to Trauma During Deployment

Bottom Line

View on ClinicalTrials.gov: NCT01336764 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2017

Primary outcome: Primary: Reduced Heart Rate During Driving (Aggregated Over Sessions) — 3.21; 9.0 beats per minute

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Cognitive reappraisal and breathing retraining (Behavioral); Control (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Palo Alto Veterans Institute for Research
Primary completion: Dec 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Reduced Heart Rate During Driving (Aggregated Over Sessions)	3.21; 9.0	—

Summary

Many U.S. military personnel are returning from Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) deployments with histories of trauma while driving in military vehicles. The proposed project aims to develop and test a rehabilitative technology aimed at enhancing emotion regulation and reducing operator-related risk during civilian driving.

Eligibility Criteria

Inclusion Criteria

Driving-related distress secondary to conditions of OEF/OIF deployment
Possesses valid driver's license
Owns vehicle registered in his/her name
Vehicle currently insured in his/her name
Drives regularly (e.g. to regularly scheduled activities such as work or school)
Drives to all driving rehabilitation appointments

Exclusion Criteria

Any moving violations since discharge from the military
Any central nervous system injury or disease
Psychotic disorder and/or any psychotic signs or symptoms
Current alcohol or substance abuse/dependence (required answer: "yes" or "no", only)
Severe Post-traumatic Stress Disorder (as indicated by a PTSD Checklist (PCL) score greater than 60)
Severe Depression(as indicated by a Beck Depression Inventory-II score greater than 28)
Amputation or restricted mobility of any limb

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01336764). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.